Nuklearmedizin - NuclearMedicine, Table of Contents Nuklearmedizin 2022; 61(05): 410-413DOI: 10.1055/a-1856-4238 Case Report Unusual accumulation of 177Lu-DOTATATE at the injection site of a COVID-19 vaccination Auffällige Anreicherung von 177Lu-DOTATATE im Bereich der Injektionstelle einer COVID-19-Impfung Christof Scheer 1 Nuklearmedizin, Universitatsklinikum Schleswig-Holstein Campus Kiel, Kiel, Germany (Ringgold ID: RIN15056) , Michael Jüptner 1 Nuklearmedizin, Universitatsklinikum Schleswig-Holstein Campus Kiel, Kiel, Germany (Ringgold ID: RIN15056) , Timo Maier 1 Nuklearmedizin, Universitatsklinikum Schleswig-Holstein Campus Kiel, Kiel, Germany (Ringgold ID: RIN15056) , Ulf Lützen 1 Nuklearmedizin, Universitatsklinikum Schleswig-Holstein Campus Kiel, Kiel, Germany (Ringgold ID: RIN15056) › Author Affiliations Recommend Article Abstract Buy Article Keywords KeywordsDOTATATE - COVID-19 - vaccination - Lu-177 - radionuclide therapy Full Text References References 1 Poeppel TD, Boy C, Bockisch A. et al. Peptide receptor radionuclide therapy for patients with somatostatin receptor expressing tumours. German Guideline (S1). Nuklearmedizin 2015; 54: 1-11 2 Anzola LK, Glaudemans AWJM, Dierckx RAJO. et al. Somatostatin receptor imaging by SPECT and PET in patients with chronic inflammatory disorders: a systematic review. Eur J Nucl Med Mol Imaging 2019; 46: 2496-2513 3 Weiler-Sagie M, Half EE. [68Ga]Ga-DOTATATE uptake due to COVID-19 vaccination.. Eur J Nucl Med Mol Imaging 2021; 48: 3743-3744 4 Dalm VASH, van Hagen PM, van Koetsveld PM. et al. Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells. Am J Physiol Endocrinol Metab 2003; 285: E344-E353 5 Falcke SE, Rühle PF, Deloch L. et al. Clinically Relevant Radiation Exposure Differentially Impacts Forms of Cell Death in Human Cells of the Innate and Adaptive Immune System. Int J Mol Sci 2018; 19: 3574
